Publications

Alberta public health disease management guidelines : tetanus

Description

Intended for public health professionals, this resource presents the recommended practices for the management and reporting of tetanus as a notifiable disease. Topics covered include: a case... More ≫

Description

Intended for public health professionals, this resource presents the recommended practices for the management and reporting of tetanus as a notifiable disease. Topics covered include: a case definition of the disease; information on reporting requirements; disease etiology; clinical presentation; diagnosis; epidemiology; key investigation; case management and treatment; and preventive measures. The guidelines were developed by Alberta Health with input and advice from Medical Officers of Health, public health nurses, public health inspectors and medical infectious disease specialists.

Tags

Alberta immunization policy

Description

The Alberta Immunization Policy outlines the policies for the provision of publicly-funded immunizations in Alberta. It contains a complete listing of vaccines and biologicals that are... More ≫

Description

The Alberta Immunization Policy outlines the policies for the provision of publicly-funded immunizations in Alberta. It contains a complete listing of vaccines and biologicals that are publicly-funded and indications for their use. PLEASE NOTE: These policies and documents are revised as new research and national recommendations become available. Please ensure you are always referencing the current version of the document. Check this page regularly for updates. The Canadian Immunization Guide recommendations should be consulted when further information about immunization is required.

Tags

Alberta public health disease management guidelines : severe acute respiratory infection (SARI)

Description

Intended for public health professionals, this resource presents the recommended practices for the management and reporting of severe acute respiratory illness (SARI) as a notifiable disease.... More ≫

Description

Intended for public health professionals, this resource presents the recommended practices for the management and reporting of severe acute respiratory illness (SARI) as a notifiable disease. Topics covered include: a case definition of the disease, information on reporting requirements and public health management guidance. The guidelines were developed by Alberta Health with input and advice from Medical Officers of Health, public health nurses, public health inspectors and medical infectious disease specialists.

Tags

Narcotic transition services

Description

A fact sheet describing the standards for narcotic transition services in the province. It includes information on legislation changes, risks, regulations and exemptions.

Tags

Tdap immunization policy for pharmacists

Description

Policy document to outline the administration of Tdap vaccine in Alberta pharmacies.

Tags

The Alberta Aids to Daily Living (AADL) bulletin [151 to current]

Description

Alberta Aids to Daily Living assists Albertans with a long-term disability, chronic illness or terminal illness, in maintaining independence in their community. AADL provides funding for basic... More ≫

Description

Alberta Aids to Daily Living assists Albertans with a long-term disability, chronic illness or terminal illness, in maintaining independence in their community. AADL provides funding for basic medical equipment and supplies to meet clinically assessed needs. The AADL bulletin provides notices, updates and reminders to AADL providers, vendors, suppliers and other interested parties.

Tags

Opioid agonist therapy Gap Coverage Program : information for health care providers

Description

Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet... More ≫

Description

Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet provides information for health care providers about the OAT Gap Coverage Program, which is designed to provide immediate, no-cost access to OAT drugs for patients who do not have supplementary health benefit coverage.

Tags

Opioid agonist therapy Gap Coverage Program : information for patients

Description

Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet... More ≫

Description

Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet provides information for patients about Gap Coverage Program, which is designed to provide immediate, no-cost access to OAT drugs for patients who do not have supplementary health benefit coverage.

Tags

Fact sheet : avian influenza and human health

Description

Fact sheet about avian influenza and human health.

Tags

On-farm slaughter operation technical guide : Meat Inspection Regulation

Description

A technical guide of regulatory requirements for parties interested in conducting an on-farm slaughter operation.

Tags